THE IMPACT OF BLUE-LIGHT CYSTOSCOPY ON RESPONSE TO INDUCTION BCG IN PATIENTS WITH HIGH-GRADE NON-MUSCLE-INVASIVE BLADDER CANCER

被引：0
|
作者：
Mikkilineni, Nina
Antoine, Samuel
Alford, Ashley
Li, Gen
Wenske, Sven
Decastro, G. Joel
McKiernan, James
Anderson, Christopher
机构：
来源：
JOURNAL OF UROLOGY | 2018年 / 199卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP08-07
引用
收藏
页码：E98 / E98
页数：1
相关论文
共 50 条
  • [21] Re: Anti-Inflammatory Use May Not Negatively Impact Oncologic Outcomes following Intravesical BCG for High-Grade Non-Muscle-Invasive Bladder Cancer
    Chang, Sam S.
    JOURNAL OF UROLOGY, 2017, 198 (05): : 978 - 978
  • [22] "Blue light" cystoscopy for detection and treatment of non-muscle invasive bladder cancer
    Mark, J. Ryan
    Gelpi-Hammerschmidt, Francisco
    Trabulsi, Edouard J.
    Gomella, Leonard G.
    CANADIAN JOURNAL OF UROLOGY, 2012, 19 (02) : 6227 - 6231
  • [23] Clinical impact of the intensity of follow-up cystoscopy in patients with high-risk non-muscle-invasive bladder cancer
    Makito Miyake
    Nobutaka Nishimura
    Yuichi Nishioka
    Tomomi Fujii
    Yuki Oda
    Tatsuki Miyamoto
    Mitsuru Tomizawa
    Takuto Shimizu
    Takuya Owari
    Kenta Ohnishi
    Shunta Hori
    Yosuke Morizawa
    Daisuke Gotoh
    Yasushi Nakai
    Kazumasa Torimoto
    Nobumichi Tanaka
    Tomoaki Imamura
    Kiyohide Fujimoto
    International Urology and Nephrology, 2024, 56 : 827 - 837
  • [24] BCG and Alternative Therapies to BCG Therapy for Non-Muscle-Invasive Bladder Cancer
    Lidagoster, Sarah
    Ben-David, Reuben
    De Leon, Benjamin
    Sfakianos, John P.
    CURRENT ONCOLOGY, 2024, 31 (02) : 1063 - 1078
  • [25] Clinical impact of the intensity of follow-up cystoscopy in patients with high-risk non-muscle-invasive bladder cancer
    Miyake, Makito
    Nishimura, Nobutaka
    Nishioka, Yuichi
    Fujii, Tomomi
    Oda, Yuki
    Miyamoto, Tatsuki
    Tomizawa, Mitsuru
    Shimizu, Takuto
    Owari, Takuya
    Ohnishi, Kenta
    Hori, Shunta
    Morizawa, Yosuke
    Gotoh, Daisuke
    Nakai, Yasushi
    Torimoto, Kazumasa
    Tanaka, Nobumichi
    Imamura, Tomoaki
    Fujimoto, Kiyohide
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2024, 56 (03) : 827 - 837
  • [26] Analysis of Autoantibodies Related to Tumor Progression in Sera from Patients with High-grade Non-muscle-invasive Bladder Cancer
    Minami, Sho
    Matsumoto, Kazumasa
    Nagashio, Ryo
    Hagiuda, Daisuke
    Fukuda, Eriko
    Goshima, Naoki
    Hattori, Manabu
    Tsuchiya, Benio
    Hachimura, Kazuo
    Jiang, Shi-Xu
    Saegusa, Makoto
    Iwamura, Masatsugu
    Sato, Yuichi
    ANTICANCER RESEARCH, 2017, 37 (12) : 6705 - 6714
  • [27] Influence of lamina propria invasion extension on T1 high-grade non-muscle-invasive bladder cancer in patients undergoing BCG or radical cystectomy
    Contieri, Roberto
    Tan, Wei Shen
    Grajales, Valentina
    Hensley, Patrick J.
    Martini, Alberto
    Bree, Kelly
    Myers, Amanda
    Nogueras-Gonzalez, Graciela
    Navai, Neema
    Dinney, Colin P.
    Guo, Charles
    Kamat, Ashish M.
    BJU INTERNATIONAL, 2024, 133 (06) : 733 - 741
  • [28] What is the optimal BCG dose in non-muscle-invasive bladder cancer?
    Witjes, J. Alfred
    EUROPEAN UROLOGY, 2007, 52 (05) : 1300 - 1302
  • [29] FLUORESCENT CYSTOSCOPY WITH HEXAMINOLEVULINATE: DIAGNOSTIC ACCURACY FOR NON-MUSCLE-INVASIVE BLADDER CANCER
    Volpe, Alessandro
    Giraudo, Davide
    Billia, Michele
    Sogni, Filippo
    Varvello, Francesco
    Zacchero, Monica
    Terrone, Carlo
    ANTICANCER RESEARCH, 2011, 31 (05) : 1904 - 1904
  • [30] A META-ANALYSIS OF BLUE LIGHT CYSTOSCOPY WITH HEXAMINOLEVULINATE IN PATIENTS WITH NON-MUSCLE INVASIVE BLADDER CANCER
    Gomella, Leonard
    Grossman, Barton
    Droller, Michael
    Schmidbauer, Jorg
    Hermann, Gregers
    Dragoescu, Octavian
    Ray, Eleanor
    Witjes, Alfred
    Karl, Alexander
    Stenzl, Arnulf
    Fradet, Yves
    Burgues, Juan
    Jocham, Dieter
    JOURNAL OF UROLOGY, 2013, 189 (04): : E528 - E528
12345